CMN Weekly (15 October 2021)

Some of the best links we picked up around the internet

By: Gorm Palmgren - Oct. 15, 2021

Top picks

Research

Industry

Clinical News

COVID-19

Reviews

Opinion

  • Future Medicine brings an interview with Geoff MacKay, who talks about new gene therapies for rare diseases. MacKay is the CEO of AVROBIO, a clinical-stage lentiviral gene therapy company that treats lysosomal disorders, and a board member of Talaris Therapeutics and Satellos Bioscience.

Tags

HashtagArticleHashtagMissing linksHashtagNewsHashtagCMN WeeklyHashtagAllogene Therapeutics, Inc.HashtagCRISPR Therapeutics AGHashtagIntellia Therapeutics, Inc.HashtagPoseida TherapeuticsHashtagPrecision BioSciences, Inc.HashtagSarepta Therapeutics

News: CMN Weekly (15 October 2021)
News: CMN Weekly (15 October 2021)
CLINICAL TRIALS
Epithelial Ovarian Cancer, (EOC), NCT05617755
Sponsors:
Arsenal Biosciences, Inc.
Indicator
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
Duchenne Muscular Dystrophy, DMD, (NCT05514249)
Sponsors:
Cure Rare Disease, Inc
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine